Decai Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Decai Zhang has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Shijia Ding
Chongqing Medical University
2 shared publications - Wei Cheng
The Center for Clinical Molecular Medical Detection The First Affiliated Hospital of Chongqing Medical University Chongqing People's Republic of China
2 shared publications Xiaoying Cai
Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China
2 shared publicationsYang Song
Department of Oncology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, 400016, China
2 shared publications- Ben Zhong Tang
The Hong Kong University of Science and Technology Clear Water Bay
1 shared publication - Bing Gu
South China University of Technology
1 shared publication
Latest Publications
- 25 March 2025
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 279, 117410
High-efficiency detection of APE1 using a defective PAM-driven CRISPR-Cas12a self-catalytic biosensor
- 25 March 2025
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 279, 117410
High-efficiency detection of APE1 using a defective PAM-driven CRISPR-Cas12a self-catalytic biosensor
- 18 November 2022
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 7 (12) , 3710-3719
Pre-Folded G-Quadruplex as a Tunable Reporter to Facilitate CRISPR/Cas12a-Based Visual Nucleic Acid Diagnosis
Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas12a-based detection strategies with a fluorophore quencher-labeled ssDNA reporter or gold nanoparticle ssDNA reporter have been widely used in point-of-care (POC) molecular diagnostics. However, the potential of these CRISPR/Cas12a strategies for POC molecular diagnostics is often compromised due to the complex labeling, high cost, and low signal-to-noise ratio. Herein, we show a pre-folded G-quadruplex (G4) structure with tunable tolerance to CRISPR/Cas12a trans-cleavage and explore its mechanism. Two G4 structures (i.e., Tel22-10 and G16C) sensitive or tolerant to CRISPR/Cas12a trans-cleavage are designed and used as signal elements to fabricate a label-free visible fluorescent strategy or "signal-on" colorimetric strategy, respectively. These two strategies facilitate an ultrasensitive visual nucleic acid determination of Group B Streptococci with a naked-eye limit of detection of 1 aM. The feasibility of the developed G4-assisted CRISPR/Cas12a strategies for real-world applications is demonstrated in clinical vaginal/anal specimens and further verified by a commercial qPCR assay. This work suggests that the proposed G4 structures with tunable tolerance can act as promising signal reporters in the CRISPR/Cas12a system to enable ultrasensitive visible nucleic acid detection.
- 18 November 2022
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 7 (12) , 3710-3719
Pre-Folded G-Quadruplex as a Tunable Reporter to Facilitate CRISPR/Cas12a-Based Visual Nucleic Acid Diagnosis
Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas12a-based detection strategies with a fluorophore quencher-labeled ssDNA reporter or gold nanoparticle ssDNA reporter have been widely used in point-of-care (POC) molecular diagnostics. However, the potential of these CRISPR/Cas12a strategies for POC molecular diagnostics is often compromised due to the complex labeling, high cost, and low signal-to-noise ratio. Herein, we show a pre-folded G-quadruplex (G4) structure with tunable tolerance to CRISPR/Cas12a trans-cleavage and explore its mechanism. Two G4 structures (i.e., Tel22-10 and G16C) sensitive or tolerant to CRISPR/Cas12a trans-cleavage are designed and used as signal elements to fabricate a label-free visible fluorescent strategy or "signal-on" colorimetric strategy, respectively. These two strategies facilitate an ultrasensitive visual nucleic acid determination of Group B Streptococci with a naked-eye limit of detection of 1 aM. The feasibility of the developed G4-assisted CRISPR/Cas12a strategies for real-world applications is demonstrated in clinical vaginal/anal specimens and further verified by a commercial qPCR assay. This work suggests that the proposed G4 structures with tunable tolerance can act as promising signal reporters in the CRISPR/Cas12a system to enable ultrasensitive visible nucleic acid detection.
- 14 October 2022
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 11 (11) , 3847-3854
Controllable crRNA Self-Transcription Aided Dual-Amplified CRISPR-Cas12a Strategy for Highly Sensitive Biosensing of FEN1 Activity
- 14 October 2022
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 11 (11) , 3847-3854
Controllable crRNA Self-Transcription Aided Dual-Amplified CRISPR-Cas12a Strategy for Highly Sensitive Biosensing of FEN1 Activity
- 14 October 2022
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1233, 340519
An ultrasensitive biosensing platform for FEN1 activity detection based on target-induced primer extension to trigger the collateral cleavage of CRISPR/Cas12a
- 14 October 2022
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1233, 340519
An ultrasensitive biosensing platform for FEN1 activity detection based on target-induced primer extension to trigger the collateral cleavage of CRISPR/Cas12a